West Pharmaceutical Services Operating Income 2012-2025 | WST
West Pharmaceutical Services annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- West Pharmaceutical Services operating income for the quarter ending September 30, 2025 was $0.168B, a 3.91% increase year-over-year.
- West Pharmaceutical Services operating income for the twelve months ending September 30, 2025 was $0.588B, a 2.92% increase year-over-year.
- West Pharmaceutical Services annual operating income for 2024 was $0.57B, a 15.7% decline from 2023.
- West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
- West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
|
West Pharmaceutical Services Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $570 |
| 2023 | $676 |
| 2022 | $734 |
| 2021 | $752 |
| 2020 | $407 |
| 2019 | $297 |
| 2018 | $240 |
| 2017 | $226 |
| 2016 | $195 |
| 2015 | $129 |
| 2014 | $182 |
| 2013 | $162 |
| 2012 | $135 |
| 2011 | $110 |
|
West Pharmaceutical Services Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $168 |
| 2025-06-30 | $154 |
| 2025-03-31 | $107 |
| 2024-12-31 | $160 |
| 2024-09-30 | $161 |
| 2024-06-30 | $126 |
| 2024-03-31 | $123 |
| 2023-12-31 | $161 |
| 2023-09-30 | $177 |
| 2023-06-30 | $183 |
| 2023-03-31 | $155 |
| 2022-12-31 | $130 |
| 2022-09-30 | $186 |
| 2022-06-30 | $228 |
| 2022-03-31 | $190 |
| 2021-12-31 | $184 |
| 2021-09-30 | $181 |
| 2021-06-30 | $211 |
| 2021-03-31 | $176 |
| 2020-12-31 | $116 |
| 2020-09-30 | $99 |
| 2020-06-30 | $104 |
| 2020-03-31 | $88 |
| 2019-12-31 | $78 |
| 2019-09-30 | $67 |
| 2019-06-30 | $81 |
| 2019-03-31 | $71 |
| 2018-12-31 | $66 |
| 2018-09-30 | $61 |
| 2018-06-30 | $60 |
| 2018-03-31 | $53 |
| 2017-12-31 | $60 |
| 2017-09-30 | $63 |
| 2017-06-30 | $42 |
| 2017-03-31 | $61 |
| 2016-12-31 | $53 |
| 2016-09-30 | $51 |
| 2016-06-30 | $61 |
| 2016-03-31 | $30 |
| 2015-12-31 | $45 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $39 |
| 2015-03-31 | $48 |
| 2014-12-31 | $45 |
| 2014-09-30 | $44 |
| 2014-06-30 | $54 |
| 2014-03-31 | $39 |
| 2013-12-31 | $37 |
| 2013-09-30 | $40 |
| 2013-06-30 | $43 |
| 2013-03-31 | $43 |
| 2012-12-31 | $32 |
| 2012-09-30 | $26 |
| 2012-06-30 | $36 |
| 2012-03-31 | $42 |
| 2011-12-31 | $27 |
| 2011-09-30 | $26 |
| 2011-06-30 | $28 |
| 2011-03-31 | $29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $17.909B | $2.893B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $117.872B | 25.61 |
| Becton Dickinson (BDX) | United States | $59.087B | 14.92 |
| Cardinal Health (CAH) | United States | $53.125B | 23.49 |
| Cooper (COO) | United States | $15.968B | 19.73 |
| Align Technology (ALGN) | United States | $13.812B | 23.45 |
| Henry Schein (HSIC) | United States | $9.430B | 16.62 |
| Merit Medical Systems (MMSI) | United States | $4.792B | 23.57 |
| DENTSPLY SIRONA (XRAY) | United States | $2.733B | 8.67 |
| CONMED (CNMD) | United States | $1.290B | 9.04 |
| STAAR Surgical (STAA) | United States | $0.866B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.127B | 15.15 |
| Lifevantage (LFVN) | United States | $0.065B | 6.67 |
| Axe Compute (AGPU) | United States | $0.008B | 0.00 |